Prf Technologies Ltd (PRFX) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket
 


Prf Technologies Ltd   (NASDAQ: PRFX)


Prf Technologies Ltd's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Prf Technologies Ltd's ROI in the fourth quarter of 2025?
Prf Technologies Ltd recorded a cumulative net loss of $-5 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -50.96%.

Within the Healthcare sector 577 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Dec 31 2025 quarter, so far to 4193, from total ROI ranking in the third quarter of 2025 at 4479.

Definition and Formula of Return on Investment



Return On Investment (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM 991.58 % 252.25 % 66.47 % -56.46 % -90.04 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 10 10 10 10 2
Return On Investment (TTM) -50.96 % -184.45 % -248.87 % -494.51 % -1615.95 %
PRFX's Overall Ranking # 4193 # 4479 # # #
Seq. Investment Change TTM 24.6 % 34.93 % 98.7 % 226.78 % -59.79 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -5 -15 -15 -15 -15




Return On Investment PRFX's Ranking
Within: No.
Industry # 242
Sector # 578
Overall # 4193

Return On Investment Statistics
High Average Low
-40.07 %
-237.83 %
-780.52 %
(Dec 31 2021)   (Dec 31 2024)



  News about Prf Technologies Ltd Return on Investment ROI

Turning the Tide Will PainReform’s PRF-110 Redefine Post-Surgical Pain Management Amid Financial Struggles,

December 27, 2024

In the realm of pharmaceutical innovation, PainReform Ltd. stands out as a clinical-stage specialty pharmaceutical company dedicated to reformulating established therapeutics for enhanced therapeutic outcomes. Recently, the company provided an update on its ongoing Phase 3 clinical trial assessing the efficacy of PRF-110 in managing post-surgical pain for patients undergoing bunionectomy a common surgical procedure aimed at correcting foot deformities.In the update released on December 27, 2024, PainReform highlighted the significance of PRF-110 as a potential game-changer in pain management. The Phase 3 trial is expected to provide critical data that could pave the way for a new standard in post-operative care, offering patients improved comfort and recovery outcomes. As the clinical trial progresses, the pharmaceutical community eagerly anticipates the results, which will shed light on PRF-110 s safety and effectiveness compared to existing treatment modalities.






Financial Statements
Prf Technologies Ltd's IV. Quarter Investments $ 10 Millions PRFX's Balance sheet
Prf Technologies Ltd's IV. Quarter Income $ -5 Millions Quarterly PRFX's Income Statement
PRFX's Income by Division See PRFX's Income by Division


PRFX Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 10 2 7 11 18
Y / Y Investment Growth 411.72 % -74.18 % -34.32 % -39.05 % 8.8 %
Net Income in Millions -5 -15 -9 -9 -7
Y / Y Net Income Growth - - - - -
Annual Return On Investment -52.51 % -780.52 % -129.08 % -79.77 % -40.07 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PRFX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PRFX's Competitors
Subscribers only: Roi for Prf Technologies Ltd's Suppliers
Subscribers only: Return On Investment for PRFX's Customers

Other Ratios
PRFX's Roa PRFX's Inventory Turnover Ratio PRFX's Growth Rates PRFX's Dividend Statistics
PRFX's Profitability Ratios PRFX's Asset Turnover Ratio PRFX's Dividend Growth
PRFX's Roe PRFX's Valuation Ratios PRFX's Financial Strength Ratios PRFX's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI


Date modified: 2026-07-07T12:39:15+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.